Arab Pharmaceuticals (EGX:ADCI) — Market Cap & Net Worth
Market Cap & Net Worth: Arab Pharmaceuticals (ADCI)
Arab Pharmaceuticals (EGX:ADCI) has a market capitalization of $315.67 (EGP16.76K) as of April 18, 2026. Listed on the EGX stock exchange, this Egypt-based company holds position #40487 globally and #25 in its home market, demonstrating a 4.72% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Arab Pharmaceuticals's stock price EGP167.60 by its total outstanding shares 100 (100.00).
Arab Pharmaceuticals Market Cap History: 2015 to 2026
Arab Pharmaceuticals's market capitalization history from 2015 to 2026. Data shows growth from $5.12 to $315.67 (46.61% CAGR).
Arab Pharmaceuticals Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Arab Pharmaceuticals's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ADCI by Market Capitalization
Companies near Arab Pharmaceuticals in the global market cap rankings as of April 18, 2026.
Key companies related to Arab Pharmaceuticals by market ranking:
- Baek Kwang Mineral Products Co. Ltd. (KQ:014580): Ranked #40478 globally with a market cap of $318.85 USD ( ₩470.50K KRW).
- TFCO4F (SA:TFCO4F): Ranked #40479 globally with a market cap of $318.66 USD ( R$1.62K BRL).
- BANQUP GROUP (BR:BANQ): Ranked #40488 globally with a market cap of $315.66 USD ( €270.00 EUR).
- FUTBOL CLUBE PORT R (MU:FBC): Ranked #40489 globally with a market cap of $315.66 USD ( €270.00 EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #40478 | Baek Kwang Mineral Products Co. Ltd. | KQ:014580 | $318.85 | ₩4705.00 |
| #40479 | TFCO4F | SA:TFCO4F | $318.66 | R$16.24 |
| #40488 | BANQUP GROUP | BR:BANQ | $315.66 | €2.70 |
| #40489 | FUTBOL CLUBE PORT R | MU:FBC | $315.66 | €2.70 |
Arab Pharmaceuticals Historical Marketcap From 2015 to 2026
Between 2015 and today, Arab Pharmaceuticals's market cap moved from $5.12 to $ 315.67, with a yearly change of 46.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | EGP315.67 | -22.35% |
| 2025 | EGP406.55 | +57.26% |
| 2024 | EGP258.53 | +97.13% |
| 2023 | EGP131.15 | +20.05% |
| 2022 | EGP109.24 | +10.35% |
| 2021 | EGP99.00 | -31.36% |
| 2020 | EGP144.22 | +81.45% |
| 2019 | EGP79.48 | +60.88% |
| 2018 | EGP49.40 | +47.89% |
| 2017 | EGP33.41 | +252.72% |
| 2016 | EGP9.47 | +85.03% |
| 2015 | EGP5.12 | -- |
End of Day Market Cap According to Different Sources
On Apr 18th, 2026 the market cap of Arab Pharmaceuticals was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $315.67 USD |
| MoneyControl | $315.67 USD |
| MarketWatch | $315.67 USD |
| marketcap.company | $315.67 USD |
| Reuters | $315.67 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Arab Pharmaceuticals
Arab Pharmaceuticals operates in various business sectors.